BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 31268621)

  • 1. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
    Kneizeh K; Alnaimi A; Noterdaeme T; Schröder J; Altiok E; Marx N; Almalla M
    J Invasive Cardiol; 2022 Mar; 34(3):E196-E201. PubMed ID: 35058376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic Shock Complicating Transcatheter Aortic Valve Replacement Due to Severe Para-Valvular Regurgitation.
    Alraies MC; Soud M; Pacha HM; Waksman R; Ben-Dor I
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):393-395. PubMed ID: 29146552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Impella 5.0 Prior to Transcatheter Aortic Valve Replacement in a Patient with Severe Aortic Stenosis and Cardiogenic Shock.
    Johnson DW; ErwinIII JP
    J Heart Valve Dis; 2017 Jul; 26(4):485-487. PubMed ID: 29302950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
    Burzotta F; Nerla R; Trani C
    J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impella support following emergency percutaneous balloon aortic valvuloplasty in patients with severe aortic valve stenosis and cardiogenic shock.
    Karatolios K; Chatzis G; Luesebrink U; Markus B; Ahrens H; Tousoulis D; Schieffer B
    Hellenic J Cardiol; 2019; 60(3):178-181. PubMed ID: 29571667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
    Fraccaro C; Campante Teles R; Tchétché D; Saia F; Bedogni F; Montorfano M; Fiorina C; Meucci F; De Benedictis M; Leonzi O; Barbierato M; Dumonteil N; Stolcova M; Maffeo D; Compagnone M; Brito J; Chieffo A; Tarantini G
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1128-1135. PubMed ID: 32627924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Impella Mechanical Circulatory Support Devices in Transcatheter Aortic Valve Replacement and Balloon Aortic Valvuloplasty: A Single-Center Experience.
    Almajed MR; Mahmood S; Obri M; Nona P; Gonzalez PE; Chiang M; Wang DD; Frisoli T; Lee J; Basir M; O'Neill B; O'Neill W; Villablanca P
    Cardiovasc Revasc Med; 2023 Aug; 53():1-7. PubMed ID: 37012106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of severe left ventricular outflow tract calcification on device failure and short-term mortality in patients undergoing TAVI.
    Jochheim D; Deseive S; Gschwendtner S; Bischoff B; Jochheim S; Hausleiter S; Zadrozny M; Baquet M; Tesche C; Massberg S; Mehilli J; Hausleiter J
    J Cardiovasc Comput Tomogr; 2020; 14(1):36-41. PubMed ID: 31327744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Schoechlin S; Brennemann T; Allali A; Ruile P; Jander N; Allgeier M; Gick M; Richardt G; Neumann FJ; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2018 May; 91(6):E56-E63. PubMed ID: 29105984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients at estimated low surgical risk undergoing transcatheter aortic valve implantation with balloon-expandable prostheses.
    Unzué L; García E; Teijeiro R; Antón BD; Del Río MR; Solís J; Alonso BR; Medina J; Rodrigo FJR; Parra FJ
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):251-256. PubMed ID: 29030013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
    Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.